| 1 | AROD, CYP19A1
|
| Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
|
| Morale MC, L'Episcopo F, Tirolo C, Giaquinta G, Caniglia S, Testa N, Arcieri P, Serra PA, Lupo G, Alberghina M, Harada N, Honda S, Panzica GC, Marchetti B.
|
| Brain Res Rev 57(2):431-43. Epub 2007 Nov 7. Review.PMID: 18063054 2008
|
| 2 | CYP19A1, AROD
|
| Variable Phenotypes Associated with Aromatase (CYP19) Insufficiency in Humans.
|
| Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, Dattani MT, Achermann JC.
|
| J Clin Endocrinol Metab 92(3):982-90. Epub 2006 Dec 12. 2007
|
| 3 | AROD, CYP19A1, AROE, CGNL1
|
| Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
|
| Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M, Bulun SE.
|
| N Engl J Med 348(19):1855-65. 2003
|